human clinical trials
Scope
Date
~
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Artificial intelligence
ESTsoft, LG Energy sign AI human education program contract
South Korea's AI service specialist company ESTsoft Corp. announced on Tuesday it has signed an education content supply contract with LG Energy Sol...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HMM embarks on biofuel ship pilot testing on global route
South Korea has begun a pilot operation of a biofuel-powered container ship on a global route, the government said on Friday. HMM Co.'s container sh...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
KOREA Investment Week
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to participate in S.Korea’s new drug project
South Korea's JW Pharmaceutical announced on Monday that its experimental hair loss drug, JW0061, has been selected for a two-year funding program b...
Aug 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Bio & Pharma
ABL Bio gets OK for phase 1 clinical trials for immune-oncology drug
New drug development company ABL Bio Inc. announced on Thursday that it has received approval from the Ministry of Food and Drug Safety of South Kor...
Aug 10, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung to unveil vision for chips resembling human senses at Tech Day
Chipmakers around the world have long aspired to develop semiconductors that can replicate human senses such as smell, hearing, vision, taste and to...
Aug 08, 2023 (Gmt+09:00)
-
Advertising & Marketing
Virtual human Lucy to sell Galaxy Z in live commerce
Lotte Home Shopping's virtual human Lucy expands her activities by selling The Galaxy Z Flip 5 and "Z Fold 5" on live commerce, following her attend...
Aug 04, 2023 (Gmt+09:00)
-
Korean chipmakers
Advanced memory is strategic asset for Korea’s chip supremacy: Hwang
South Korea, home to the world’s two largest memory chipmakers – Samsung Electronics Co. and SK Hynix Inc. – has been the dominant...
Aug 03, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to make first domestic 6-in-1 vaccine for infants
South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Retail
Lotte to open Vietnam's largest shopping mall in Hanoi
Lotte Shopping Co., the retail arm of South Korea's fifth-largest conglomerate Lotte Group, announced plans on Thursday to inaugurate its extensive ...
Jul 27, 2023 (Gmt+09:00)
-
Artificial intelligence
Lotte's virtual human Lucy to debut in Thailand
South Korea's Lotte Home Shopping unveiled a plan on Wednesday to introduce its virtual influencer, Lucy, to Southeast Asia's burgeoning live commer...
Jul 26, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Innovation seeks to license allergy therapy to Japan in 2023
South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...
Jul 17, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia completes flying drone interception test
Hyundai Wia Corp., an auto parts and defense unit of Hyundai Motor Group, announced on Thursday that the first shooting trial of its anti-drone syst...
Jul 06, 2023 (Gmt+09:00)
-
Food & Beverage
Dongwon F&B selects virtual human family as brand model
South Korea's food and beverage company Dongwon F&B Co. announced on Friday that it has selected a virtual human family as the model for its pre...
Jun 30, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported car market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google